Publications 2013

  1. Harrison L, Ananworanich J, Hamadache D, Compagnucci A, Penazzato M, Bunupuradah T, Mazza A, Ramos JT, Flynn J, Rampon O, Mellado Pena MJ, Floret D, Marczynska M, Puga A, Forcat S, Riault Y, Lallemant M, Castro H, Gibb DM, Giaquinto C; On Behalf of the Paediatric European Network for Treatment of AIDS (PENTA) 11 Trial Team. Adherence to Antiretroviral Therapy and Acceptability of Planned Treatment Interruptions in HIV-Infected Children. AIDS Behav. 2013 Jan;17(1):193-202. doi: 10.1007/s10461-012-0197-y.
  2. IeDEA Pediatric Working Group. A survey of paediatric HIV programmatic and clinical management practices in Asia and sub-Saharan Africa–the International epidemiologic Databases to Evaluate AIDS (IeDEA). J Int AIDS Soc. 2013 Jan 15;16:17998. doi: 10.7448/IAS.16.1.17998.
  3. Tangkijvanich P, Sa-nguanmoo P, Avihingsanon A, Ruxrungtham K, Poovorawan K, Poovorawan Y. Characterization of Hepatitis B Virus Mutations in Untreated Co-infected Patients with HIV and HBV Based on Complete Genome Sequencing. J Med Virol. 2013 Jan;85(1):16-25. doi: 10.1002/jmv.23430. Epub 2012 Sep 28.
  4. Nguyen HL, Charpentier C, Nguyen N, de Truchis P, Molina JM, Ruxrungtham K, Delaugerre C. Longitudinal analysis of integrase N155H variants in heavily treated patients failing raltegravir-based regimens. HIV Med. 2013 Feb;14(2):85-91. doi: 10.1111/j.1468-1293.2012.01039.x. Epub 2012 Sep 20.
  5. Bunupuradah T, Duong T, Compagnucci A, McMaster P, Bernardi S, Kanjanavanit S, Rampon O, Faye A, Saïdi Y, Riault Y, De Rossi A,Klein N, Ananworanich J, Gibb D; PENTA 11 Extension Study Group. Outcomes after reinitiating antiretroviral therapy in children randomized to planned treatment interruptions. AIDS. 2013 Feb 20;27(4):579-89. doi: 10.1097/QAD.0b013e32835c1181.
  6. Oyomopito RA, Li PC, Sungkanuparph S, Phanuphak P, Tee KK, Sirisanthana T, Kantipong P, Oka S, Lee CK, Kamarulzaman A, Choi JY, Sohn AH, Law M, Chen YM; TREAT Asia Studies to Evaluate Resistance (TASER) and The TREAT Asia HIV Observational Database. Evaluating immunologic response and clinical deterioration in treatment-naive patients initiating first-line therapies infected with HIV-1 CRF01_AE and subtype B. J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):293-300. doi: 10.1097/QAI.0b013e31827a2e8f.
  7. Puthanakit T, Bunupuradah T, Kosalaraksa P, Vibol U, Hansudewechakul R, Ubolyam S, Suwanlerk T, Kanjanavanit S, Ngampiyaskul C, Wongsawat J, Luesomboon W, Vonthanak S, Ananworanich J, Ruxrungtham K on behalf of the PREDICT study group. Prevalence of HLA-B*5701 among HIV-infected children in Thailand and Cambodia: implications for abacavir use. Pediatr Infect Dis J. 2013 Mar;32(3):252-3. doi: 10.1097/INF.0b013e3182745dba.
  8. Puthanakit T, Bunupuradah T, Kosalaraksa P, Vibol U, Hansudewechakul R, Ubolyam S, Suwanlerk T, Kanjanavanit S, Ngampiyaskul C, Wongsawat J, Luesomboon W, Vonthanak S, Ananworanich J, Ruxrungtham K; PREDICT Study Group. Prevalence of human leukocyte antigen-B*5701 among HIV-infected children in Thailand and Cambodia: implications for abacavir use. Pediatr Infect Dis J. 2013 Mar;32(3):252-3. doi: 10.1097/INF.0b013e3182745dba.
  9. Sungkanuparph S, Jiamsakul A, Kiertiburanakul S, Sirivichayakul S, Praparattanapan J, Kantor R; TREAT Asia Studies to Evaluate Resistance. Rilpivirine resistance-associated mutations among antiretroviral-naive patients infected with HIV-1 in Asia. J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):e98-100. doi: 10.1097/QAI.0b013e31827a34b2.
  10. Landolt NK, Phanuphak N, Ubolyam S, Pinyakorn S, Kriengsinyot R, Ahluwalia J, Thongpaeng P, Gorowara M, Thammajaruk N, Chaithongwongwatthana S, Lange JM, Ananworanich J. Efavirenz, in contrast to nevirapine, is associated with unfavorable progesterone and antiretroviral levels when coadministered with combined oral contraceptives. J Acquir Immune Defic Syndr. 2013 Apr 15;62(5):534-9. doi: 10.1097/QAI.0b013e31827e8f98.
  11. Kosalaraksa P, Ananworanich J, Puthanakit T, Pinyakorn S, Lumbiganon P, Chuanjaroen T, Chobkarjing U, Phanuphak P,Pancharoen C, Bunupuradah T; HIV-NAT 077 Study Team. Long-term lopinavir/ritonavir monotherapy in HIV-infected children. Pediatr Infect Dis J. 2013 Apr;32(4):350-3. doi: 10.1097/INF.0b013e31827b1bd3.
  12. Matthews GV, Ali RJ, Avihingsanon A, Amin J, Hammond R, Bowden S, Lewin SR, Sasadeusz J, Littlejohn M, Locarnini SL, Ruxrungtham K, Dore GJ. Quantitative HBsAg and HBeAg predict hepatitis B seroconversion after initiation of HAART in HIV-HBV coinfected individuals. PLoS One. 2013 Apr 9;8(4):e61297. doi: 10.1371/journal.pone.0061297. Print 2013.
  13. Andrade BB, Hullsiek KH, Boulware DR, Rupert A, French MA, Ruxrungtham K, Montes ML, Price H, Barreiro P, Audsley J, Sher A, Lewin SR, Sereti I; INSIGHT Study Group. Biomarkers of inflammation and coagulation are associated with mortality and hepatitis flares in persons coinfected with HIV and hepatitis viruses. J Infect Dis. 2013 May 1;207(9):1379-88. doi: 10.1093/infdis/jit033. Epub 2013 Jan 18.
  14. Puthanakit T, Ananworanich J, Vonthanak S, Kosalaraksa P, Hansudewechakul R, van der Lugt J, Kerr SJ, Kanjanavanit S,Ngampiyaskul C, Wongsawat J, Luesomboon W, Vibol U, Pruksakaew K, Suwarnlerk T, Apornpong T, Ratanadilok K, Paul R,Mofenson LM, Fox L, Valcour V, Brouwers P, Ruxrungtham K; PREDICT Study Group. Cognitive function and neurodevelopmental outcomes in HIV-infected Children older than 1 year of age randomized to early versus deferred antiretroviral therapy: the PREDICT neurodevelopmental study. Pediatr Infect Dis J. 2013 May;32(5):501-8. doi: 10.1097/INF.0b013e31827fb19d.
  15. Bunupuradah T, Ananworanich J, Puthanakit T. Double-dose hepatitis B revaccination in nonresponsive HIV-infected adolescents. J Int Assoc Provid AIDS Care. 2013 May-Jun;12(3):157-8. doi: 10.1177/1545109712473651. Epub 2013 Feb 19.
  16. South East Asia Infectious Disease Clinical Research Network. Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trial. BMJ. 2013 May 30;346:f3039. doi: 10.1136/bmj.f3039.
  17. Matthews GV, Seaberg EC, Avihingsanon A, Bowden S, Dore GJ, Lewin SR, Sasadeusz J, Revill PA, Littlejohn M, Hoy JF, Finlayson R, Ruxrungtham K, Saulynas M, Locarnini S, Thio CL. Thio Patterns and causes of suboptimal response to tenofovir based therapy in HIV-HBV infected individuals. Clin Infect Dis. 2013 May;56(9):e87-94. doi: 10.1093/cid/cit002. Epub 2013 Jan 11.
  18. Wright S, Boyd MA, Yunihastuti E, Law M, Sirisanthana T, Hoy J, Pujari S, Lee MP, Petoumenos K; International Epidemiologic Databases to Evaluate AIDS (IeDEA) Asia-Pacific HIV Observational Database (APHOD). Rates and factors associated with major modifications to first-line combination antiretroviral therapy: results from the Asia-Pacific region. PLoS One. 2013 Jun 28;8(6):e64902. doi: 10.1371/journal.pone.0064902. Print 2013.
  19. SECOND-LINE Study Group, Boyd MA, Kumarasamy N, Moore CL, Nwizu C, Losso MH, Mohapi L, Martin A, Kerr S, Sohn AH, Teppler H, Van de Steen O, Molina JM, Emery S, Cooper DA. Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): a randomised, open-label, non-inferiority study. Lancet. 2013 Jun 15;381(9883):2091-9. doi: 10.1016/S0140-6736(13)61164-2.
  20. Durier N, Ananworanich J, Apornpong T, Ubolyam S, Kerr SJ, Mahanontharit A, Ferradini L, Ruxrungtham K, Avihingsanon A. Cytomegalovirus Viremia in Thai HIV-infected Patients on Antiretroviral Therapy: Prevalence and Associated Mortality. Clin Infect Dis. 2013 Jul;57(1):147-55. doi: 10.1093/cid/cit173. Epub 2013 Mar 19.
  21. Kancheva Landolt N, Ramautarsing RA, Phanuphak N, Teeratakulpisarn N, Pinyakorn S, Rodbamrung P, Chaithongwongwatthana S, Ananworanich J. Factors associated with the use of irreversible contraception and continuous use of reversible contraception in a cohort of HIV-positive women. Contraception. 2013 Jul;88(1):67-73. doi: 10.1016/j.contraception.2012.10.017. Epub 2012 Nov 21.
  22. Phanuphak N, Teeratakulpisarn N, Triratanachat S, Keelawat S, Pankam T, Kerr SJ, Deesua A, Tantbirojn P, Numto S, Phanuphak P, Palefsky JM, Ananworanich J. High prevalence and incidence of high-grade anal intraepithelial neoplasia among young Thai men who have sex with men with and without HIV. AIDS. 2013 Jul 17;27(11):1753-62. doi: 10.1097/QAD.0b013e328360a509.
  23. Rongkavilit C, Naar-King S, Wang B, Panthong A, Bunupuradah T, Parsons JT, Phonphithak S, Koken JA, Saengcharnchai P, Phanuphak P. Motivational interviewing targeting risk behaviors for youth living with HIV in Thailand. AIDS Behav. 2013 Jul;17(6):2063-74. doi: 10.1007/s10461-013-0407-2.
  24. Byakwaga H, Petoumenos K, Ananworanich J, Zhang F, Boyd MA, Sirisanthana T, Li PC, Lee C, Mean CV, Saphonn V, Omar SF, Pujari S, Phanuphak P, Lim PL, Kumarasamy N, Chen YM, Merati TP, Sungkanuparph S, Ditangco R, Oka S, Tau G, Zhou J, Law MG, Emery S. Predictors of clinical progression in HIV-1-infected adults initiating combination antiretroviral therapy with advanced disease in the Asia-Pacific region: results from the TREAT Asia HIV observational database. J Int Assoc Provid AIDS Care. 2013 Jul-Aug;12(4):270-7. doi: 10.1177/1545109712469684. Epub 2013 Feb 19.
  25. Tu E, Swenson LC, Land S, Pett S, Emery S, Marks K, Kelleher AD, Kaye S, Kaiser R, Schuelter E, Harrigan R; MARCH Laboratory Group and the MARCH Study Group. Results of external quality assessment for proviral DNA testing of HIV tropism in the Maraviroc Switch collaborative study. J Clin Microbiol. 2013 Jul;51(7):2063-71. doi: 10.1128/JCM.00510-13. Epub 2013 Apr 17.
  26. Chalermchai T, Hiransuthikul N, Tangkijvanich P, Pinyakorn S, Avihingsanon A, Ananworanich J. Risk factors of chronic hepatitis in antiretroviral-treated HIV infection, without hepatitis B or C viral infection. AIDS Res Ther. 2013 Jul 26;10:21. doi: 10.1186/1742-6405-10-21. eCollection 2013.
  27. Saira K, Lin X, DePasse JV, Halpin R, Twaddle A, Stockwell T, Angus B, Cozzi-Lepri A, Delfino M, Dugan V, Dwyer DE, Freiberg M, Horban A, Losso M, Lynfield R, Wentworth DN, Holmes EC, Davey R, Wentworth DE, Ghedin E; INSIGHT FLU002 Study Group; INSIGHT FLU003 Study Group. Sequence analysis of in vivo defective interfering-like RNA of influenza A H1N1 pandemic virus. J Virol. 2013 Jul;87(14):8064-74. doi: 10.1128/JVI.00240-13. Epub 2013 May 15.
  28. Cahn P, Ruxrungtham K, Gazzard B, Diaz RS, Gori A, Kotler DP, Vriesema A, Georgiou NA, Garssen J, Clerici M, Lange JM; Blinded Nutritional Study for Immunity and Tolerance Evaluation Study Team. The immunomodulatory nutritional intervention NR100157 reduced CD4+ T-cell decline and immune activation: a 1-year multicenter randomized controlled double-blind trial in HIV-infected persons not receiving antiretroviral therapy (The BITE Study). Clin Infect Dis. 2013 Jul;57(1):139-46. doi: 10.1093/cid/cit171. Epub 2013 Mar 19.
  29. Phanuphak N, Teeratakulpisarn N, Pankam T, Kerr SJ, Barisri J, Deesua A, Rodbamrung P, Hongchookiat P, Chomchey N, Phanuphak P, Sohn AH, Ananworanich J, Palefsky JM. Anal human papillomavirus infection among Thai men who have sex with men with and without HIV infection: prevalence, incidence, and persistence. J Acquir Immune Defic Syndr. 2013 Aug 1;63(4):472-9. doi: 10.1097/QAI.0b013e3182918a5a.
  30. Phanuphak N, Teeratakulpisarn N, Lim C, Changnam T, Kerr S, Deesua A, Hongchookiat P, Rodbamrung P, Numto S, Barisri J, Phanuphak P, Keelawat S, Sohn AH, Ananworanich J, Triratanachat S. Comparable performance of conventional and liquid-based cytology in diagnosing anal intraepithelial neoplasia in HIV-infected and -uninfected Thai men who have sex with men. J Acquir Immune Defic Syndr. 2013 Aug 1;63(4):464-71. doi: 10.1097/QAI.0b013e3182928ea6.
  31. Martin A, Moore C, Mallon PW, Hoy J, Emery S, Belloso W, Phanuphak P, Ferret S, Cooper DA, Boyd MA. Bone mineral density in HIV participants randomized to raltegravir and lopinavir/ritonavir compared with standard second line therapy. AIDS. 2013 Sep 24;27(15):2403-11. doi: 10.1097/01.aids.0000432534.47217.b4.
  32. Akapirat S, Avihingsanon A, Ananworanich J, Schuetz A, Ramasoota P, Luplertlop N, Ono K, Ikuta K, Utachee P, Kameoka M, Leaungwutiwong P. Variables influencing anti-human immunodeficiency virus type 1 neutralizing human monoclonal antibody (NHMAB) production among infected Thais. Southeast Asian J Trop Med Public Health. 2013 Sep;44(5):825-41.
  33. Bunupuradah T, Kariminia A, Chan KC, Ramautarsing R, Huy BV, Han N, Nallusamy R, Hansudewechakul R, Saphonn V,Sirisanthana V, Chokephaibulkit K, Kurniati N, Kumarasamy N, Yusoff NK, Razali K, Fong SM, Sohn AH, Lumbiganon P; TREAT Asia Pediatric HIV Observational Database. Incidence and predictors of severe anemia in Asian HIV-infected children using first-line antiretroviral therapy. Int J Infect Dis. 2013 Oct;17(10):e806-10. doi: 10.1016/j.ijid.2013.04.006. Epub 2013 Jun 10.
  34. Hsu DC, Kerr SJ, Iampornsin T, Pett SL, Avihingsanon A, Thongpaeng P, Zaunders JJ, Ubolyam S, Ananworanich J, Kelleher AD, Cooper DA. Restoration of CMV-Specific-CD4 T cells with ART occurs early and is greater in those with more advanced immunodeficiency. PLoS One. 2013 Oct 10;8(10):e77479. doi: 10.1371/journal.pone.0077479. eCollection 2013.
  35. Chokephaibulkit K, Saksawad R, Bunupuradah T, Rungmaitree S, Phongsamart W, Lapphra K, Maleesatharn A, Puthanakit T. Prevalence of vitamin D deficiency among perinatally HIV-infected Thai adolescents receiving antiretroviral therapy. Pediatr Infect Dis J. 2013 Nov;32(11):1237-9. doi: 10.1097/INF.0b013e31829e7a5c.
  36. Avihingsanon A, Kerr SJ, Punyawudho B, van der Lugt J, Gorowara M, Ananworanich J, Lange JMA, Cooper DA, Phanuphak P, Burger DM, Ruxrungtham K. Short communication: Aging not gender is associated with high atazanavir plasma concentrations in Asian HIV-infected patients. AIDS Res Hum Retroviruses. 2013 Dec;29(12):1541-6. doi: 10.1089/aid.2013.0069. Epub 2013 Oct 2.
  37. Bjerk SM, Baker JV, Emery S, Neuhaus J, Angus B, Gordin FM, Pett SL, Stephan C, Kunisaki KM; INSIGHT SMART Study Group. Biomarkers and bacterial pneumonia risk in patients with treated HIV infection: a case-control study. PLoS One. 2013;8(2):e56249. doi: 10.1371/journal.pone.0056249. Epub 2013 Feb 15.
  38. Babiker AG, Emery S, Fätkenheuer G, Gordin FM, Grund B, Lundgren JD, Neaton JD, Pett SL, Phillips A, Touloumi G, Vjechaj MJ; INSIGHT START Study Group. Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study. Clin Trials. 2013;10(1 Suppl):S5-S36. doi: 10.1177/1740774512440342. Epub 2012 Apr 30.
  39. Ramautarsing RA, van der Lugt J, Gorowara M, Sophonphan J, Ananworanich J, Lange JMA, Burger DM, Phanuphak P, Ruxthungtham K, Avihingsanon A. Pharmacokinetics and 48-week safety and efficacy of generic lopinavir/ritonavir in Thai HIV-infected patients. Antivir Ther. 2013;18(2):249-52. doi: 10.3851/IMP2324. Epub 2012 Aug 23.
  40. Bunupuradah T, Puthanakit T, Fahey P, Kariminia A, Yusoff NK, Khanh TH, Sohn AH, Chokephaibulkit K, Lumbiganon P,Hansudewechakul R, Razali K, Kurniati N, Huy BV, Sudjaritruk T, Kumarasamy N, Fong SM, Saphonn V, Ananworanich J; TApHOD. Second-line protease inhibitor-based HAART after failing non-nucleoside reverse transcriptase inhibitor-based regimens in Asian HIV-infected children. Antivir Ther. 2013;18(4):591-8. doi: 10.3851/IMP2494. Epub 2013 Jan 7.
  41. Davey RT Jr, Lynfield R, Dwyer DE, Losso MH, Cozzi-Lepri A, Wentworth D, Lane HC, Dewar R, Rupert A, Metcalf JA, Pett SL, Uyeki TM, Bruguera JM, Angus B, Cummins N, Lundgren J, Neaton JD; INSIGHT FLU 002 & 003 Study Groups. The association between serum biomarkers and disease outcome in influenza A(H1N1)pdm09 virus infection: results of two international observational cohort studies. PLoS One. 2013;8(2):e57121. doi: 10.1371/journal.pone.0057121. Epub 2013 Feb 27.
  42. Landolt NK, Phanuphak N, Teeratakulpisarn N, Kriengsinyot R, Ahluwalia J, Pinyakorn S, Chaithongwongwatthana S, Ananworanich J. Uptake and continuous use of copper intrauterine device in a cohort of HIV-positive women. AIDS Care. 2013;25(6):710-4. doi: 10.1080/09540121.2012.752786. Epub 2013 Jan 11.